Ron Kern uses his extensive scientific research experience in biochemistry and molecular biology to assist a wide range of clients, including Fortune 500 companies, start-up companies and universities, to develop and implement patent strategies in the life science arena. Ron specializes in the areas of protein therapeutics, diagnostics, medical devices, and laboratory instruments and techniques. His practice includes drafting and prosecuting U.S. and foreign patents; advising clients of the risks associated with practicing a technology of interest; advising clients of the patentability of a technology of interest; drafting clearance opinions; drafting ex parte reexamination petitions and inter partes review petitions; and counseling clients on growing and maintaining patent portfolios.